3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Thoracic
1
Other neoplasm
1
Head & Neck
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
33
Pain, Postoperative
4
Chronic Pain
3
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Breast Diseases
2
Brain Neoplasms
2
Agnosia
2
Vulvodynia
1
Uterine Cervical Neoplasms
1
Skin Diseases
1
Seroma
1
Recurrence
1
Radiation Injuries
1
Postoperative Hemorrhage
1
Peripheral Nervous System Diseases
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, B-Cell, Marginal Zone
1
Hot Flashes
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Gangliosidosis, GM1
1
Gangliosidoses
1
Interventions
pembrolizumab
24
Nivolumab
7
Early Intervention, Educational
7
Methods
6
durvalumab
5
aldesleukin
5
Trastuzumab
5
Paclitaxel
5
Fulvestrant
5
Carboplatin
5
atezolizumab
4
Surveys and Questionnaires
4
Patient Navigation
4
Docetaxel
4
Cyclophosphamide
4
Biopsy
4
fludarabine
3
Mass Screening
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Interleukin-2
3
Gene Expression Profiling
3
Fluorouracil
3
Educational Status
3
Bevacizumab
3
tremelimumab
2
spartalizumab
2
sargramostim
2
palbociclib
2
fludarabine phosphate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Sodium Chloride
×
Breast
×
Clear all
NCT04237090
2020-10-12
PREMED-F1
Ciusss de L'Est de l'Île de Montréal
Phase 3
Completed
27 enrolled